In preterm infants with recurrent apnoea, methylxanthine reduces the number of episodes and the use of mechanical ventilation in the short term; caffeine is also associated with improved longer term outcomes
- PMID: 21447523
- DOI: 10.1136/ebm1207
In preterm infants with recurrent apnoea, methylxanthine reduces the number of episodes and the use of mechanical ventilation in the short term; caffeine is also associated with improved longer term outcomes
Comment on
-
Methylxanthine treatment for apnoea in preterm infants.Cochrane Database Syst Rev. 2010 Dec 8;2010(12):CD000140. doi: 10.1002/14651858.CD000140.pub2. Cochrane Database Syst Rev. 2010. PMID: 21154343 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources